Stay updated on Pembrolizumab in Advanced Head and Neck Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Head and Neck Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated to include detailed information about a Phase III clinical study evaluating pembrolizumab as a treatment for Stage III-IVA resectable locoregionally advanced head and neck squamous cell carcinoma. Key details such as study design, eligibility criteria, and locations for participation have been added.
    Difference
    100%
    Check dated 2025-06-13T16:23:13.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed study information regarding a clinical trial for pembrolizumab in treating advanced head and neck squamous cell carcinoma. This includes critical data on study design, eligibility criteria, and locations involved in the trial.
    Difference
    91%
    Check dated 2025-06-06T10:03:17.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.6%
    Check dated 2025-05-30T04:48:47.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-23T02:05:33.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T06:06:42.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed descriptions of a clinical study involving pembrolizumab and the addition of new identifiers and treatment details related to head and neck neoplasms, specifically concerning radiotherapy and cisplatin.
    Difference
    16%
    Check dated 2025-04-16T17:32:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Head and Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.